Zoonotic diseases, also known as zoonoses, have emerged as a persistent threat to global health, emphasizing the intricate links between animals and humans. These diseases, ranging from influenza to coronaviruses, underscore the importance of understanding and mitigating the risks associated with cross-species transmission. The interconnectedness of our ecosystems and the intensification of human-animal interactions amplify the potential for zoonotic spillover events. The dynamics of zoonotic diseases are complex, often influenced by factors such as habitat destruction, climate change, and wildlife trade. The 21st century has witnessed several high-profile outbreaks, including the H1N1 influenza pandemic in 2009 and the ongoing COVID-19 pandemic caused by the SARS-CoV-2 virus. The unprecedented global impact of these events has prompted a reevaluation of public health strategies, emphasizing the need for proactive surveillance, rapid response capabilities, and international collaboration. Efforts to curb zoonotic diseases involve a multidisciplinary approach, incorporating expertise from fields like veterinary medicine, ecology, epidemiology, and public health. Surveillance and early detection mechanisms are crucial for identifying potential hotspots and preventing the spillover of pathogens from animals to humans. Moreover, education and awareness campaigns aimed at promoting responsible interactions with wildlife, sustainable agricultural practices, and improved hygiene standards play pivotal roles in reducing the risk of zoonotic transmission.
Title : Bioterrorism through the ages: Historical perspective, emerging threats, and medical countermeasures
Claudia Ferreira, Sorbonne University, France
Title : Changing population immunity to COVID-19 in the context of infection, vaccination, and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : From bench to preclinical evaluation: LL-37-derived peptides for combating orthopedic infections
Vincenzo Pennone, IRCCS Galeazzi Sant’Ambrogio Hospital, Italy
Title : Extensively drug-resistant bacterial infections: Confronting a global crisis with urgent solutions in prevention, surveillance, and treatment
Yazdan Mirzanejad, University of British Columbia, Canada
Title : Measles vaccination coverage indicators in 2023 and advance towards measles elimination and eradication by 2030
Pedro Plans Rubio, College of Physicians of Barcelona, Spain
Title : Personalized and precision medicine (PPM) as a unique healthcare model to se-cure the human healthcare, wellness and biosafety through the view of public health, network driven healthcare services and lifestyle management
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation